Pharmaceutical firm Granules India today said its consolidated net profit rose by 41.99% to Rs 7.98 crore during the quarter ended December 31, 2011, vis-a-vis the same period last fiscal.
The company had posted a consolidated net profit of Rs 5.62 crore for the quarter ended December 31, 2010, Granules India said in a statement.
Consolidated net sales of the company stood at Rs 185.72 crore for the quarter ended December 31, 2011, as against Rs 128 crore for the quarter ended December 31, 2010, it added.
Commenting on the results, Granules India MD Krishna Prasad said: "We have successfully gained market share because customers appreciate our blend of quality, customer service and value... [besides] gaining approval for our Naproxen sodium tablet ANDA and receiving MHRA approval for our Ibuprofen API."
Shares of Granules India settled at Rs 65.80 apiece on the BSE today, down 0.15% from their previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app